...
机译:肝细胞癌的立体定向体放射治疗:患者选择和毒性的预测因子
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
IRCSS Humanitas Clin &
Res Ctr Radiotherapy &
Radiosurg Dept Via Manzoni 56 I-20089 Milan Italy;
Stereotactic radiotherapy; SBRT; SABR; Liver primary tumors; Hepatocellular carcinoma; Barcelona Clinic Liver Cancer System;
机译:对临床术后T1-3N0M0非小细胞肺癌患者随后化疗诱导化疗对诱导化疗的比较疗效和毒性
机译:立体定向放疗治疗肝细胞癌患者的放射诱发肝毒性的定义
机译:肝细胞癌(HCC)中的白蛋白 - 胆红素(ALBI)模型可能更好地预测传统上低风险的肝硬化患者的肝衰竭(SBRT)
机译:IL-12是一种有用的标记,以预测放疗中的临床结果:IL-12的下调增加了局部晚期肝细胞癌的治疗失败
机译:Tomotherapy对呼吸运动矫正立体定向放疗患者肿瘤定位的评估
机译:立体定向体放射治疗在肝细胞癌患者中不适合龙动脉化疗栓塞(肝细胞癌立体定向放疗临床疗效研究)的疗效
机译:立体定向体放射治疗在肝细胞癌患者中不适合龙动脉化疗栓塞(肝细胞癌立体定向放疗临床疗效研究)的疗效
机译:免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。